Sal Daher, CFA is an investor in SQZ Biotech.
If you'd like to consider investing alongside Sal in this type of company, please enter your e-mail address here:
Listen to Sal's interview of Armon Sharei, CEO of SQZ Biotech here
Current Podcast Episode
The way cancer is treated is about to change.
Close monitoring during treatment will become possible, telling us within days with much greater precision if a treatment is working or not. Long-term monitoring of patients in remission will also be revolutionized by making fewer biopsies necessary and detecting relapses much earlier. All these promises come from the technology developed in the lab of Çağrı [Cha-ree] Savran at Purdue University that is being commercialized in Savran Technologies.
The brilliant and charming Professor Savran was my guest in this laugh-filled episode. He told how he went from a childhood in Turkey to studying in some of America’s most prominent universities. He opened my eyes to the startup-friendly climate at Purdue University and he explained how his invention came about. Don’t miss this accessible and fun report from the most consequential frontier of innovation.